Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil
· Delayed Price · Currency is BRL 33.57
-1.20 (-3.45%)
At close: Mar 6, 2026
Neurocrine Biosciences Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 67,949 | 77,890 | 85,477 | 62,816 | 60,702 | 45,018 | Upgrade
|
| Market Cap Growth | 2.92% | -8.88% | 36.07% | 3.48% | 34.84% | -3.20% | Upgrade
|
| Enterprise Value | 62,691 | 74,392 | 79,652 | 58,830 | 57,973 | 43,273 | Upgrade
|
| Last Close Price | 33.57 | 40.32 | 42.53 | 32.30 | 31.58 | 23.62 | Upgrade
|
| PE Ratio | 25.78 | 29.55 | 40.49 | 51.85 | 74.32 | 90.18 | Upgrade
|
| PS Ratio | 4.31 | 4.94 | 5.87 | 6.86 | 7.71 | 7.13 | Upgrade
|
| PB Ratio | 3.79 | 4.35 | 5.34 | 5.80 | 6.72 | 5.88 | Upgrade
|
| P/TBV Ratio | 3.79 | 4.35 | 5.34 | 5.91 | 6.90 | 5.88 | Upgrade
|
| P/FCF Ratio | 16.48 | 18.89 | 24.80 | 35.80 | 35.56 | 34.66 | Upgrade
|
| P/OCF Ratio | 15.76 | 18.07 | 23.21 | 33.20 | 33.83 | 31.50 | Upgrade
|
| EV/Sales Ratio | 4.21 | 4.72 | 5.47 | 6.43 | 7.37 | 6.85 | Upgrade
|
| EV/EBITDA Ratio | 16.53 | 20.26 | 20.64 | 29.14 | 41.44 | 35.51 | Upgrade
|
| EV/EBIT Ratio | 18.90 | 21.22 | 21.57 | 30.71 | 44.04 | 37.38 | Upgrade
|
| EV/FCF Ratio | 15.20 | 18.04 | 23.11 | 33.53 | 33.96 | 33.32 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.18 | 0.19 | 0.15 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 0.65 | 0.65 | 0.68 | 0.99 | 0.94 | 1.88 | Upgrade
|
| Debt / FCF Ratio | 0.63 | 0.63 | 0.82 | 1.19 | 0.81 | 1.89 | Upgrade
|
| Net Debt / Equity Ratio | -0.31 | -0.31 | -0.24 | -0.27 | -0.42 | -0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.51 | -1.51 | -0.99 | -1.45 | -2.74 | -1.24 | Upgrade
|
| Net Debt / FCF Ratio | -1.35 | -1.35 | -1.11 | -1.67 | -2.25 | -1.16 | Upgrade
|
| Asset Turnover | 0.69 | 0.69 | 0.68 | 0.67 | 0.67 | 0.60 | Upgrade
|
| Inventory Turnover | 16.90 | 16.90 | 15.99 | 16.48 | 14.85 | 11.71 | Upgrade
|
| Quick Ratio | 2.92 | 2.92 | 3.06 | 2.25 | 2.49 | 3.65 | Upgrade
|
| Current Ratio | 3.39 | 3.39 | 3.40 | 2.45 | 2.70 | 3.96 | Upgrade
|
| Return on Equity (ROE) | 16.38% | 16.38% | 14.16% | 12.68% | 10.03% | 7.17% | Upgrade
|
| Return on Assets (ROA) | 9.53% | 9.53% | 10.71% | 8.78% | 7.01% | 6.82% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.73% | 20.50% | 23.31% | 22.75% | 17.26% | 19.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.40% | 16.40% | 18.60% | 15.20% | 13.60% | 11.40% | Upgrade
|
| Earnings Yield | 3.88% | 3.38% | 2.47% | 1.93% | 1.35% | 1.11% | Upgrade
|
| FCF Yield | 6.07% | 5.29% | 4.03% | 2.79% | 2.81% | 2.89% | Upgrade
|
| Buyback Yield / Dilution | 1.16% | 1.16% | -2.67% | -2.12% | -1.02% | -0.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.